Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Search Results for: clinical trials – Page 16

April 2022 CLL Bloodline

Over the course of a year of monthly meetings, The CLL Society Bloodline will teach the BASICS needed to understand CLL.  It will also provide news, help with the acronyms and

CLL Caregiver Lifehacks Podcast

Caregiver Lifehacks: CLL Edition Podcast Listen Here CLL Society and OffScrip Health partnered to produce this three-episode podcast series providing a home for the often unspoken thoughts and feelings of the

ASH 2021: Matching-Adjusted Indirect Treatment Comparison (MAIC) of Acalabrutinib Alone or in Combination with Obinutuzumab Versus Ibrutinib or Venetoclax Plus Obinutuzumab in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

Acalabrutinib (A) and ibrutinib (I) are both highly effective Bruton tyrosine kinase (BTK) inhibitors approved for the treatment of chronic lymphocytic leukemia (CLL) and given as continuous treatments until disease progression or unacceptable toxicity.

CLL / SLL Patient Journey

Mark Hoffman shares his CLL journey from diagnosis to participating in a clinical trial as a frontline treatment and his current remission.

Cancer and COVID-19: A Proposed Mechanism with Therapeutic Interventions

In our second interview, Dr. Leyfman shared his research on COVID-19 and cancer patients presented at the American Society of Clinical Oncology’s Annual Meeting or ASCO 2021. He discussed a radically different approach with an experimental cellular therapy, mesenchymal stem cells, which demonstrated a 91% overall survival and 100% survival in patients younger than 85 years old at one month after a single treatment.

Chemotherapy

Chemotherapy Chemotherapy damages the cells’ DNA and non-specifically kills anything that grows quickly, such as cancer cells, but also skin, hair, gut, and normal blood cells. In CLL / SLL, common

Didn't find what you where looking for?

Try our advanced search page!